tradingkey.logo

Fortrea Holdings Inc

FTRE

6.420USD

+0.960+17.58%
Cierre 08/04, 16:00ETCotizaciones retrasadas 15 min
581.01MCap. mercado
PérdidaP/E TTM

Fortrea Holdings Inc

6.420

+0.960+17.58%
Más Datos de Fortrea Holdings Inc Compañía
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Información de la empresa
Símbolo de cotizaciónFTRE
Nombre de la empresaFortrea Holdings Inc
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoMr. Anshul Thakrala
Número de empleados15500
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 16
Dirección8 Moore Drive
CiudadDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27709
Teléfono18774950816
Sitio Webhttps://www.fortrea.com/
Símbolo de cotizaciónFTRE
Fecha de salida a bolsaJun 16, 2023
Director ejecutivoMr. Anshul Thakrala
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
35.63K
+25.69%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
35.63K
+25.69%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
North America
309.50M
47.52%
Europe
200.30M
30.75%
Other
141.50M
21.73%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 30 de jul
Actualizado: mié., 30 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
12.10%
The Vanguard Group, Inc.
9.60%
Sessa Capital
5.19%
Corvex Management LP
4.94%
BlackRock Financial Management, Inc.
4.87%
Other
63.30%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
12.10%
The Vanguard Group, Inc.
9.60%
Sessa Capital
5.19%
Corvex Management LP
4.94%
BlackRock Financial Management, Inc.
4.87%
Other
63.30%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
45.16%
Hedge Fund
25.39%
Investment Advisor/Hedge Fund
20.49%
Research Firm
6.06%
Pension Fund
1.14%
Individual Investor
0.40%
Bank and Trust
0.38%
Venture Capital
0.09%
Endowment Fund
0.07%
Other
0.83%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
936
89.76M
99.18%
-22.88M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
10.95M
12.1%
-180.41K
-1.62%
Mar 31, 2025
The Vanguard Group, Inc.
9.85M
10.88%
+12.67K
+0.13%
Mar 31, 2025
Sessa Capital
4.69M
5.19%
-1.96M
-29.51%
Mar 31, 2025
Corvex Management LP
4.47M
4.94%
+994.00K
+28.56%
Mar 31, 2025
BlackRock Financial Management, Inc.
4.40M
4.87%
+13.79K
+0.31%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.05M
4.48%
-2.13M
-34.48%
Mar 31, 2025
Morgan Stanley & Co. LLC
3.89M
4.29%
+3.33M
+600.25%
Mar 31, 2025
Millennium Management LLC
3.50M
3.87%
+2.88M
+466.44%
Mar 31, 2025
State Street Global Advisors (US)
3.26M
3.61%
-107.87K
-3.20%
Mar 31, 2025
Beck, Mack & Oliver LLC
2.94M
3.24%
-2.70M
-47.92%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
LeaderShares Activist Leaders ETF
0.99%
Brandes US Small-Mid Cap Value ETF
0.62%
Invesco S&P Spin-Off ETF
0.44%
Invesco S&P SmallCap Health Care ETF
0.32%
VictoryShares US Small Mid Cap Value Momentum ETF
0.19%
Invesco S&P SmallCap 600 Revenue ETF
0.18%
Vanguard US Value Factor ETF
0.18%
Humankind US Stock ETF
0.12%
Invesco S&P SmallCap 600 Pure Value ETF
0.12%
SPDR S&P 600 Small Cap Value ETF
0.07%
Ver más
LeaderShares Activist Leaders ETF
Proporción0.99%
Brandes US Small-Mid Cap Value ETF
Proporción0.62%
Invesco S&P Spin-Off ETF
Proporción0.44%
Invesco S&P SmallCap Health Care ETF
Proporción0.32%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporción0.19%
Invesco S&P SmallCap 600 Revenue ETF
Proporción0.18%
Vanguard US Value Factor ETF
Proporción0.18%
Humankind US Stock ETF
Proporción0.12%
Invesco S&P SmallCap 600 Pure Value ETF
Proporción0.12%
SPDR S&P 600 Small Cap Value ETF
Proporción0.07%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI